Professor
Vanderbilt University, Tennessee, United States
Dr. Jeffrey Rathmell studies T cell biology with a focus on metabolic mechanisms that regulate lymphocyte fate and function. He has developed an interdisciplinary basic and translational research program using genetic and biochemical approaches to discover immunometabolic and microenvironmental mechanisms that drive cancer and autoimmunity. After undergraduate studies at the University of Northern Iowa, he received his PhD in Immunology at Stanford University. He then performed postdoctoral studies at the University of Chicago and University of Pennsylvania prior to joining the faculty at Duke University and subsequently Vanderbilt University Medical Center. In this time, he showed that lymphocyte metabolism is dynamically regulated and was the first to show that each T cell subset adopts a specific metabolic program. He has explored these metabolic pathways to identify molecular targets to modulate immune cells in inflammatory diseases or in tumor microenvironments to enhance immunotherapy. He joined Vanderbilt in 2015 to found and direct the Vanderbilt Center for Immunobiology as the Cornelius Vanderbilt Professor of Immunobiology. Dr. Rathmell is co-leader for the Vanderbilt-Ingram Cancer Center Program in Host-Tumor Interactions. Dr. Rathmell has been twice recognized with the Charles Randell Prize Faculty Teaching Award for the Molecular Pathology and Immunology Graduate Program. Dr. Rathmell is also a Fellow of the American Association for the Advancement of Science, is a Highly Cited Researcher, and was named a scholar of the Leukemia & Lymphoma Society, the Bernard Osher Fellow of the American Asthma Foundation, and a William Paul Distinguished Innovator of the Lupus Research Alliance.
Disclosure information not submitted.
Metabolic Dysfunction in the Inflammatory Microenvironment
Friday, June 27, 2025
8:30am - 9:00am East Coast USA Time
